KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Assets Average (2016 - 2025)

Pfizer (PFE) has disclosed Assets Average for 17 consecutive years, with $131.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average fell 39.32% to $131.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $131.2 billion, a 39.32% decrease, with the full-year FY2025 number at $210.6 billion, down 4.28% from a year prior.
  • Assets Average was $131.2 billion for Q4 2025 at Pfizer, up from $130.1 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $224.0 billion in Q1 2024 to a low of $47.7 billion in Q4 2022.
  • A 5-year average of $155.8 billion and a median of $146.9 billion in 2021 define the central range for Assets Average.
  • Biggest YoY gain for Assets Average was 363.26% in 2023; the steepest drop was 70.29% in 2023.
  • Pfizer's Assets Average stood at $113.9 billion in 2021, then plummeted by 58.12% to $47.7 billion in 2022, then surged by 363.26% to $221.0 billion in 2023, then decreased by 2.15% to $216.2 billion in 2024, then crashed by 39.32% to $131.2 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Assets Average are $131.2 billion (Q4 2025), $130.1 billion (Q3 2025), and $130.1 billion (Q2 2025).